IO Biotech presents at J.P. Morgan conference; confirms cash runway into Q4 2025

IO Biotech, Inc.

Company presenting at 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024.
Updated corporate presentation posted; confirms projected cash runway through Q4 2025.
No new clinical data or financial results disclosed in the filing.

item 7.01 item 9.01

IO Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-003947

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.